396. Ausra Voskiene,Vytautas Mickevicius, and Gema Mikulskiene ARKIVOC 2007 (xv)303-314.397. Ranjana Aggarwal and Rajiv Kumar Department of Chemistry,Kurukshetra<strong>University</strong>, Kurukshetra, Haryana, India Synthetic Communications 2009, 39 ,2169–2177398. S. Tripathi ; B. R. Pandey and co-workers ; Indian J. Physical pharmacol. 1980,24(2), 155.399. Zalgislaw K. ; Zbigniew and A. Seffan ; Acta. Pol. Pharma., 1979, 36(6), 645 ;Chem. Abstr., 1980, 93, 204525e.400. Z. Brozozowsk E. Pomarnaka ; Acta. Pol. Pharm., 1980, 37(4), 1378 ; Chem.Abstr., 1981, 25, 80807.401. Ashok kumar, R. S. Verma and B. P. Jagu ; J. Ind. Chem. Soc. 1990, 67, 120.402. D. Bhaskar Reddy, T. Seshama, B. Seehaiha & M. V. Ramma Reddy ; Indian J.Chem., 1991, 30(B), 46.403. J. Zamocka, D. Dvoracknov, J. Heger, A. Nagy and D. Mynorcik ; Chem. Zveshi1980, (34), 556 ; Chem. Abstr., 1981, 94, 139741b.404. Wellinga Kobus, Eussen Jacobus H. H. ; Eur. Pat. EP 1988, 269 141 (Cl C07D231/06) ; Chem. Abstr., 1989, 110, 8204.405. Uhlendorf Joachim Kubl. Peter, Leyck, Sigurd ; Ger. Off. DE 1988, 3, 705, 933 (ClC07D 417104) ; Chem. Abstr., 1989, 110, 389870.406. K. Tern and Zolzislaw ; Acta. Pol. Pharm., 1979, 36(3), 227 ; Chem. Abstr., 1980,93, 4650r.407. V. S. Jolly and Manish Pathak ; J. Ind. Chem. Soc., 1991, 68, 304.408. M. Koos, M. Repas, B. Steiner, D. Myanrnick ; Chem. Pap. 1990, 44(1), 105-10 ;Chem. Abstr., 1990, 113, 78232y.409. Yamashita Hiroyuti, Odata Mocoto, Lizuka et al. ; Eur. Pat. Appl. EP 295695 (ClC07D 401/6) ; Chem. Abstr., 1989, 111, 23510.410. G. R. Subbanwad and Y. B. Vibhuta ; J. Indian Chem. Soc. 1992, 69, 781.411. F. M. Abd-El-Latif, M. A. Barsi, As. Maghraby, M. Z. Abady and D. Dopi ; J. IndianChem. Soc. 1995, 72, 641-643.412. Ismail, Mohamed Mohsen, El-Gendy, Adel A., Abdou, Madia A., El-Falaha, BhagatM. A.., Alexandria ; J. Pharm. Sci. 1993, 7(1), 41-4 ; Chem. Abstr., 1996, 124,8687d.182References…..
413. Sarhan, El-Taher Z., Mohammed, Shadia A., Mikhael Anwar N ; Alexandria ; J.Pharma, Sci., 1993, 7(1), 41-4 ; Chem. Abstr., 1996, 124, 8687d.414. Wang, Zhong-Y, Shi-Hai-Jain, Shi Hao- Xin ; Hecheng Huqxue, 1995, 3(3), 226-30 ;Chem. Abstr., 1996, 124, 8687d.415. Delay Francois (Fermenich S. A.) Patentschriff (Switz) ; Chem. Abstr., 1992, 117,90276f.416. F. Manna, F. Chiments, A. Belasco, Cenicola M. L. , D’Amico et al. ; Chem. Abstr.,1993, 118, 80902p.417. Grant N. ; Mishriky Newel, Asaad F. M. Fawzy N. G., Pharmazie. 1998, 53(8), 543-547 (Eng) Chem. Abstr., 1998, 129, 260380c418. Jatin Upadhyay, Utpal Dave and Hansa Parekh ; Chem. Abstr., 1992, 116,128768n.419. H. J. Vikani ; K. D. Ladva and Hansa Parekh ; J. of Sciences Islamic Republic ofIran 1993, 4, 3.420. P. Patel, S. Koregaokar, M. Shah and H. Parekh ; IL Pharaco 1996, 51(1), 59-63.421. Fernandes Y. J. ; Parekh Hansa ; J. Indian Chem. Soc., 1997, 74(B), 238-240 ;Chem. Abstr., 1997, 127, 5037t.422. Sorathia S. D., Patel V. B. ; Parikh A. R. ; I. J. Chem. Sec B, Org. Ind. Med. Chem.,1997, 36(B), (7) 630-632 ; Chem. Abstr., 1998, 128, 61454j.423. Udupi R. H., Rao, S. Narayan, Bhat A. R. ; Indian J. Hetero Chem. 1998, 7(3), 217-220 ; Chem. Abstr., 1998, 128, 308434i.424. Kadu V. B., Doshi A. G. ; Orient J. Chem., 1997, 13(3), 285-288 ; Chem. Abstr.,1998, 128, 192588d.425. Patil S. D., Gudadhe, Ukesh C. S., Jamode U. S. ; Asian J. Chem. 2000, 12(1),195-198 ; Chem. Abstr., 2000, 132, 180515x.426. L. Claisen and O. Lowmann ; Chem. Ber.,1888, 21, 1149.427. A. Guelico ; Chem. Heterocycl. Compd. 1962, 17, 1428. N. K. Kochetkov and S. D. Sokolova ; Adv. Heterocycl. Chem. 1968, 2, 365.429. S. B. Lohiya and B. J. Ghiya ; Indian J. Chem. ; 1986, 279-82.430. Naik S. M., Naik H. B. ; Orient J. Chem. ; 1998, 14(1), 167-168 ; Chem. Abstr.,1998, 129, 216539n.431. El. Kholy Y. M. (Faculty of Science, Helwan <strong>University</strong>, Cairo, Egypt J. Chem.39(5), 249-258, National Information and Documentation centre.183References…..
- Page 3:
The Sarvodaya Education Society’s
- Page 6 and 7:
selfless help, moral support and gu
- Page 9 and 10:
Introduction and Spectral studies .
- Page 11 and 12:
“STUDIES ON SOME HETEROCYCLICENTI
- Page 13 and 14:
Pyrimidine derivatives have been pr
- Page 15 and 16:
Isoxazole derivative synthesized by
- Page 17 and 18:
“STUDIES ON SOMEHETEROCYCLIC ENTI
- Page 19 and 20:
(b) Pharmacokinetics: It is derived
- Page 21 and 22:
(C) Drug DevelopmentMany natural pr
- Page 23 and 24:
The process of drug design is exten
- Page 25 and 26:
(l) Non steroidal anti-inflammatory
- Page 27 and 28:
INTRODUCTIONThe aza-indolizine cont
- Page 29 and 30:
PHARMACEUTICAL IMPORTANTMuch resear
- Page 31 and 32:
Compd. R 1 R 2 R 3a :- H 7-Me-6,8-B
- Page 33 and 34:
S. Kristjan, Gudmundsson and A. Bra
- Page 35 and 36:
STUDIES ON IMIDAZOPYRIDINE DERIVATI
- Page 37 and 38:
(a) Chalcones with monoethanolamine
- Page 39 and 40:
Das B.P. et al. 111 have found that
- Page 41 and 42:
Furthermore, Alcaraz M.J, et al. 13
- Page 43 and 44:
REACTION SCHEMECl+ClOClOClClCH 3NH
- Page 45 and 46:
Instrument : SHIMADZU FTIR 8400 Spe
- Page 47 and 48:
SignalNo.SignalPosition(δppm)Relat
- Page 49 and 50:
ANTIMICROBIAL ACTIVITYProducts : Ch
- Page 51 and 52:
The reaction mixture was poured on
- Page 53 and 54:
TABLE NO.- 1A BIOLOGICAL SCREENING
- Page 55 and 56:
PART-IISTUDIES ON PYRIMIDINES
- Page 57 and 58:
The self consistent (pi)electron de
- Page 59 and 60:
class of dye viz. trichloro pyrimid
- Page 61 and 62:
ability to cleave nucleic acid targ
- Page 63 and 64:
SSNHNHoONOoONOo(11) (12)oOHThe Pyri
- Page 65 and 66:
called ABPP or bropirimine(2-amino-
- Page 67 and 68:
acid so that it could be utilized f
- Page 69 and 70:
have reported the 5-substitutedfuro
- Page 71 and 72:
maturation of the viral mRNA molecu
- Page 73 and 74:
Nevertheless, these compounds const
- Page 75 and 76:
OHHNCH 3Cl(CH 2 )nSNNR 2R 1N H 2NSR
- Page 77 and 78:
SECTION-ISTUDIES ONOXOPYRIMIDINES
- Page 79 and 80:
PHARMACEUTICAL IMPORTANCEIn recent
- Page 81 and 82:
REACTION SCHEMECH 3NNCHOCl10% KOH R
- Page 83 and 84:
INSTRUMENT :SHIMADZU FTIR 8400 Spec
- Page 85 and 86:
SignalNo.SignalPosition(δppm)Relat
- Page 87 and 88:
EXPERIMENTALSynthesis and therapeut
- Page 89 and 90:
TABLE NO.- 2(IB)PHYSICAL CONSTANTS
- Page 91 and 92:
INTRODUCTIONThiopyrimidine derivati
- Page 93 and 94:
H 3 COHNRH 3 CH 3 CNHS( IV ) R = ar
- Page 95 and 96:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 97 and 98:
IR SPECTRAL STUDIES OF 6-(2-(4-CHLO
- Page 99 and 100:
NMR SPECTRAL STUDIES OF 6-(2-(4-CHL
- Page 101 and 102:
MASS SPECTRAL STUDIES OF 6-(2-(4-CH
- Page 103 and 104:
[F] Antimicrobial activity of 6-(2-
- Page 105 and 106:
SECTION-IIISTUDIES ONAMINOPYRIMIDIN
- Page 107 and 108:
ArCHO+ArCOCH3NaOHMethanolR R 1ONaOH
- Page 109 and 110:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 111 and 112:
IR SPECTRAL STUDIES OF 4-(2-(4-CHLO
- Page 113 and 114:
NMR SPECTRAL STUDIES OF 4-(2-(4-CHL
- Page 115 and 116:
MASS SPECTRAL STUDIES OF 4-(2-(4-CH
- Page 117 and 118:
[F] Antimicrobial activity of 4-(2-
- Page 119 and 120:
PART-IIISTUDIES ONCYCLOHEXENONES
- Page 121 and 122:
2. Michael addition of chalcone wit
- Page 123 and 124:
Rheinheimer J. et al. 381have synth
- Page 125 and 126:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 127 and 128:
IR SPECTRAL STUDIES OF ETHYL-6-(2-(
- Page 129 and 130:
NMR SPECTRAL STUDIES OF ETHYL-6-(2-
- Page 131 and 132:
MASS SPECTRAL STUDIES OF ETHYL-6-(2
- Page 133 and 134:
Antimicrobial testing was carried o
- Page 135 and 136:
PART-IVSTUDIES ON PYRAZOLINES
- Page 137 and 138:
H 2 C= CHCN + Ar - NHNH 2NArN(3) 2
- Page 139 and 140:
PHARMACEUTICAL IMPORTANCE :2- Pyraz
- Page 141 and 142:
Kadu et al. 424 and antimicrobial b
- Page 143 and 144:
REACTION SCHEMECH 3NNClCHO10% KOHRO
- Page 145 and 146:
Instrument : SHIMADZU FTIR 8400 Spe
- Page 147 and 148:
SignalNo.SignalPosition(δppm)Relat
- Page 149 and 150:
EXPERIMENTALSynthesis and therapeut
- Page 151 and 152:
TABLE NO.- 4(B)PHYSICAL CONSTANTS O
- Page 153 and 154: INTRODUCTION:Isoxazole come under t
- Page 155 and 156: PHARMACEUTICAL IMPORTANCE :Isoxazol
- Page 157 and 158: SYNTHESISAND THERAPEUTIC EVALUATION
- Page 159 and 160: IR SPECTRAL STUDIES OF 2-(4-CHLOROP
- Page 161 and 162: NMR SPECTRAL STUDIES OF 2-(4-CHLORO
- Page 163 and 164: MASS SPECTRAL STUDIES OF 2-(4-CHLOR
- Page 165 and 166: [F]Antimicrobial activity of 2-(4-c
- Page 167 and 168: PART-VISTUDIES ON OXIRANES
- Page 169 and 170: ( iii ) Epoxidation can also been c
- Page 171 and 172: Moreover, Nomura Yutaka et al. 487
- Page 173 and 174: SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 175 and 176: IR SPECTRAL STUDIES OF (3-(2-(4-CHL
- Page 177 and 178: NMR SPECTRAL STUDIES OF (3-(2-(4-CH
- Page 179 and 180: MASS SPECTRAL STUDIES OF (3-(2-(4-C
- Page 181 and 182: [F] Antimicrobial activity of (3-(2
- Page 184 and 185: 1. J. A. Joule and K. Mills; Hetero
- Page 186 and 187: 37. James J. Kaminski, D. G. perkin
- Page 188 and 189: 78. Ms. B. S. Hastak and B. J. Ghiy
- Page 190 and 191: 116. V. R. Mudalir and V. Joshi ; I
- Page 192 and 193: 150. S. Inoue, A. J. Saggimoto and
- Page 194 and 195: 197. S. S. Bahekar, D. B. Shinde; A
- Page 196 and 197: 238. A. Kreutzberger and M. Sellhei
- Page 198 and 199: 280. See, for example, W. H. Prusof
- Page 200 and 201: 326. C. W. Whitehead and J. J. Trav
- Page 202 and 203: 366. Nagarjan K., Shenoy S. J.; Ind
- Page 206 and 207: 432. Solankee Sejal; Prajapati Yoge
- Page 208 and 209: 463. Mishra Ashutosh ; Jain Sanmati
- Page 210 and 211: 496. Kaneko Mashami, Saitoh Yutaka,
- Page 212 and 213: CH 3CH 3NNClNNClORHNONRRRC 6 H 5 -
- Page 214 and 215: CH 3CH 3NNClNNClEtOOCORHNNRRRC 6 H